These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32664921)

  • 41. In-hospital mortality of cardiogenic shock complicating ST-elevation myocardial infarction in Malaysia: a retrospective analysis of the Malaysian National Cardiovascular Database (NCVD) registry.
    Venkatason P; Zubairi YZ; Wan Ahmad WA; Hafidz MI; Ismail MD; Hadi MF; Zuhdi ASM
    BMJ Open; 2019 May; 9(5):e025734. PubMed ID: 31061031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Temporal trends in the epidemiology, management, and outcome of patients with cardiogenic shock complicating acute coronary syndromes.
    De Luca L; Olivari Z; Farina A; Gonzini L; Lucci D; Di Chiara A; Casella G; Chiarella F; Boccanelli A; Di Pasquale G; De Servi S; Bovenzi FM; Gulizia MM; Savonitto S
    Eur J Heart Fail; 2015 Nov; 17(11):1124-32. PubMed ID: 26339723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intra-Aortic Balloon Counterpulsation in Patients With Chronic Heart Failure and Cardiogenic Shock: Clinical Response and Predictors of Stabilization.
    Sintek MA; Gdowski M; Lindman BR; Nassif M; Lavine KJ; Novak E; Bach RG; Silvestry SC; Mann DL; Joseph SM
    J Card Fail; 2015 Nov; 21(11):868-76. PubMed ID: 26164215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Admission hyperglycemia in patients with acute coronary syndrome complicated by cardiogenic shock.
    Jaśkiewicz F; Supeł K; Koniarek W; Zielińska M
    Cardiol J; 2015; 22(3):290-5. PubMed ID: 25428733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prognostic value of oxygen challenge test for patients with cardiogenic shock receiving extracorporeal membrane oxygenation].
    Dong L; Zhang X; Liang F; Yu X; Yang T; Li L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Dec; 29(12):1102-1106. PubMed ID: 29216944
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcomes among patients requiring unplanned intra-aortic balloon pump reinsertion in cardiogenic shock.
    Howard EW; Steiner J; Torguson R; Chen F; Cooper HA
    Cardiovasc Revasc Med; 2014 Apr; 15(3):137-40. PubMed ID: 24661832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intra-aortic balloon pump combined with mechanical ventilation for treating patients aged > 60 years in cardiogenic shock: Retrospective analysis.
    Liu H; Wu X; Zhao X; Zhu P; Han L
    J Int Med Res; 2016 Jun; 44(3):433-43. PubMed ID: 27020597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic impact of baseline and residual SYNTAX scores in cardiogenic shock.
    Javanainen T; Sans-Roselló J; Harjola VP; Nieminen MS; Lassus J; Sionis A; Varpula M; Jurkko R
    Catheter Cardiovasc Interv; 2019 Jan; 93(1):1-8. PubMed ID: 30208254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry.
    Hunziker L; Radovanovic D; Jeger R; Pedrazzini G; Cuculi F; Urban P; Erne P; Rickli H; Pilgrim T;
    Circ Cardiovasc Interv; 2019 Apr; 12(4):e007293. PubMed ID: 30943781
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI.
    Zeymer U; Bauer T; Hamm C; Zahn R; Weidinger F; Seabra-Gomes R; Hochadel M; Marco J; Gitt A
    EuroIntervention; 2011 Aug; 7(4):437-41. PubMed ID: 21764661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The ability to achieve complete revascularization is associated with improved in-hospital survival in cardiogenic shock due to myocardial infarction: Manitoba cardiogenic SHOCK Registry investigators.
    Hussain F; Philipp RK; Ducas RA; Elliott J; Džavík V; Jassal DS; Tam JW; Roberts D; Garber PJ; Ducas J
    Catheter Cardiovasc Interv; 2011 Oct; 78(4):540-8. PubMed ID: 21547996
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients.
    Schäfer A; Werner N; Burkhoff D; Sieweke JT; Zietzer A; Masyuk M; Junker Udesen NL; Westenfeld R; Møller JE
    Front Cardiovasc Med; 2020; 7():74. PubMed ID: 32478095
    [No Abstract]   [Full Text] [Related]  

  • 53. A "no-option" left main PCI registry: outcomes and predictors of in hospital mortality-utility of the logistic EuroSCORE.
    Elmayergi N; Nguyen T; Hiebert B; Philipp RK; Jassal DS; Tam JW; Hussain F
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):361-9. PubMed ID: 23197480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predicting mortality in cardiogenic shock secondary to ACS requiring short-term mechanical circulatory support: The ACS-MCS score.
    Marashly Q; Taleb I; Kyriakopoulos CP; Dranow E; Jones TL; Tandar A; Overton SD; Tonna JE; Stoddard K; Wever-Pinzon O; Kemeyou L; Koliopoulou AG; Shah KS; Nourian K; Richins TJ; Burnham TS; Welt FG; McKellar SH; Nativi-Nicolau J; Drakos SG
    Catheter Cardiovasc Interv; 2021 Dec; 98(7):1275-1284. PubMed ID: 33682308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protein-based cardiogenic shock patient classifier.
    Rueda F; Borràs E; García-García C; Iborra-Egea O; Revuelta-López E; Harjola VP; Cediel G; Lassus J; Tarvasmäki T; Mebazaa A; Sabidó E; Bayés-Genís A
    Eur Heart J; 2019 Aug; 40(32):2684-2694. PubMed ID: 31204432
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trends in sex differences in clinical characteristics, treatment strategies, and mortality in patients with ST-elevation myocardial infarction in Poland from 2005 to 2011.
    Zandecki L; Sadowski M; Janion M; Gierlotka M; Gasior M; Polonski L
    Coron Artery Dis; 2017 Aug; 28(5):417-425. PubMed ID: 28489635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intra-aortic balloon pump in acute chest pain and cardiogenic shock - a long-term follow-up.
    Bendz B; Gude E; Ragnarsson A; Endresen K; Aaberge L; Geiran O; Simonsen S
    Scand Cardiovasc J; 2019 Dec; 53(6):337-341. PubMed ID: 31476881
    [No Abstract]   [Full Text] [Related]  

  • 58. The influence of diabetes on in-hospital and long-term mortality in patients with myocardial infarction complicated by cardiogenic shock: results from the PL-ACS registry.
    Gąsior M; Pres D; Gierlotka M; Hawranek M; Słonka G; Lekston A; Buszman P; Kalarus Z; Zembala M; Poloński L
    Kardiol Pol; 2012; 70(12):1215-24. PubMed ID: 23264238
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of initial 24-h urine output on short-term outcomes in patients with ST-segment elevation myocardial infarction admitted without cardiogenic shock and renal dysfunction.
    Huang B; Yang Y; Zhu J; Liang Y; Tan H; Yu L; Gao X; Li J; Zhang H; Wang J; Wan H
    Atherosclerosis; 2015 May; 240(1):137-43. PubMed ID: 25782166
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.
    Fuernau G; Pöss J; Denks D; Desch S; Heine GH; Eitel I; Seiler S; de Waha S; Ewen S; Link A; Schuler G; Adams V; Böhm M; Thiele H
    Crit Care; 2014 Dec; 18(6):713. PubMed ID: 25528363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.